BSE: 532540 NSE: Aarti Drugs ISIN: INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.
Aarti Drugs Overview:
| Stock Symbol in NSE | Stock Symbol in BSE | Current Price | Market Cap. (Cr) | P/E Ratio | Current EPS |
|---|
Aarti Drugs Sector Performance and Peer Comparison with Sector Analysis:
Did You Know?
- Aarti Drugs is the
- Its Belong to Group.
Balance Sheets & Profit & Loss Account:
| Mar 2010 | Mar 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|
Aarti Drugs Share Price Forecast Based on Current Growth +5/-5:
Share Price and EPS Forecast Based on Current Average Growth Rates:
| Next 5 Year (CG) | Next 10 Year (CG) | Next 20 Year (CG) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:
| Next 5 Year (CG+5%) | Next 10 Year (CG+10%) | Next 20 Year (CG+20%) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:
| Next 5 Year (CG-5%) | Next 10 Year (CG-10%) | Next 20 Year (CG-20%) |
|---|
Aarti Drugs Quarterly Result, Date & Street Estimate:
Fundamental Analysis of Aarti Drugs:
Aarti Drugs Share Long Term Investment Price Target:
Aarti Drugs Fundamentals SWAT Analysis by AMT
Strengths, Weaknesses, Opportunities, and Threats of Aarti Drugs
S
- Strengths Analysis will coming Soon.
W
- Weakness Analysis will coming Soon.
O
- Opportunity Analysis will coming Soon.
T
- Threats Analysis will coming Soon.
Where we can See Aarti Drugs in Next 5 Year, 10 Year & 20 Year?
Technical Analysis of Aarti Drugs:
Aarti Drugs Share Weekly Swing Trading Price Target:
| Demand And Supply Zone | Support Levels | Support Price | Resistance Levels | Resistance Price |
|---|
Aarti Drugs Share Today Intraday Price Target:
| V-Guard Share Price IntradayTarget Today [Short Selling] | V-Guard Share Price IntradayTarget Today [Long Buying] |
|---|
FAQ on Aarti Drugs:
Yes, Aarti Drugs is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.
Aarti Drugs is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.
Currently Aarti Drugs is Trading at P/E Ratio which is
Both and working as a
Do to Covid-19 pandemic Aarti Drugs Share drastically fall.
Its depend on when you and at what price you have buy this share, Aarti Drugs at 20-25 P/E Ration is a excellent buy call for long Term Investment.
Aarti Drugs’s Products/Projects:
| Products/Projects | Description/Valuation |
| A. | |
| B. | |
| C. |
IPO, Split, Bonus, Dividend Buyback History:
Aarti Drugs First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.
[ninja_tables id=”*******************SBDB*****************************”
Company Profile:
| CEO Name | Prakash M Patil |
| CFO Name | Adhish P Patil |
| CEO Salary | N/A |
| Company Address | Sarigam INA, Gujarat 396155 |
| Contact Number | 22-24019025 |
| Email Address | corporatehr@aartidrugs.com |
Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.